cardiovascular drugs chris g. wherrett, md, frcpc department of anesthesiology ottawa hospital...
TRANSCRIPT
![Page 1: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/1.jpg)
Cardiovascular Drugs
Chris G. Wherrett, MD, FRCPC
Department of Anesthesiology
Ottawa Hospital General Campus
October 11, 2012
![Page 2: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/2.jpg)
2
Objectives
To highlight clinically relevant features of basic clinical pharmacology of cardiovascular drugs used in anesthesia and critical care
To highlight clinically irrelevant features of these drugs that find their way into exams
To stimulate some interest in a topic that can be overwhelming
![Page 3: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/3.jpg)
3
References
1) Stoelting, 4th Edition (2006)– Chapters 12-16
2) TOH Parenteral Drug ManualInfonet > Pharmacy Dept.
![Page 4: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/4.jpg)
4
Q & A Format
Not real exam questions
Anything goes
Previous sessions “format confusing”– I’ve simplified some questions
– Please ask for clarification
– Intended to challenge in a different way
I’ve addressed all comments in feedback that I could understand
Some of you may not agree with this format
![Page 5: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/5.jpg)
5
Re: Propranolol
1) Greatest incidence of CNS effects of beta
blockers 2) Half life after IV
administration 3-4 hr 3) Depression of myocardial
contractility and reduction in heart rate occur at similar serum levels
4) Maximum IV dose 0.2 mg/kg
5) Has ISA and MSA 6) Increases SVR
![Page 6: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/6.jpg)
6
Re: Propranolol (2)
1) Greatest incidence of CNS effects of beta
blockers 2) Half life after IV
administration 3-4 hr 3) Depression of myocardial
contractility and reduction in heart rate occur at similar serum levels
4) Maximum IV dose 0.2 mg/kg
5) Has ISA and MSA 6) Increases SVR
![Page 7: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/7.jpg)
7
Metoprolol overdose should be treated with:
1) Atropine
2) Dopamine
3) Isoproterenol
4) Dobutamine
5) Glucagon
6) Ca++
![Page 8: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/8.jpg)
8
Beta blockers, actions:
1) Decrease myocardial ischemia through effects on myocardial oxygen consumption, diastolic perfusion period and collateral
flow 2) Decrease infarct size in AMI 3) Decrease morbidity and
mortality in AMI 4) CXD in hypertrophic
cardiomyopathies 5) Improve EF in patients with
CHF 6) Reduce mortality in
noncardiac surgery
![Page 9: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/9.jpg)
9
Sotalol:
1) Nonselective Beta antagonist
2) Indicated for supraventricular dysrhythmias and life-threatening ventricular tachydysrhythmias
3) Effect due to blockade of cardiac beta receptors to SNS
4) Safety profile similar to other Beta blockers
5) Less effect on contractility than other Beta blockers
![Page 10: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/10.jpg)
10
Timolol:
1) Useful to treat glaucoma because it decreases production of aqueous humour
2) Deleted
3) When administered topically, systemic effects are rare
4) Has less Beta-2 effect than Betaxolol
![Page 11: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/11.jpg)
11
Which antihypertensive drugs cause cerebral
vasodilation? 1) SNP 2) NTG 3) Hydralazine 4) Enalaprilat 5) Trimethaphan 6) Labetalol, Esmolol 7) Diltiazem, Nifedipine,
Nimodipine 8) Phenoxybenzamine
![Page 12: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/12.jpg)
12
Contra-Indicated in hypertrophic
cardiomyopathy: 1) Nifedipine 2) Propranolol 3) NTG 4) Ephedrine 5) Dobutamine
![Page 13: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/13.jpg)
13
CEBs, hemodynamic effects:
1) Negative inotropes 2) Negative chronotropes 3) Diltiazem has least
negative inotropy 4) Verapamil can
significantly decrease myocardial function
5) Diltiazem is the most potent coronary vasodilator
![Page 14: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/14.jpg)
14
CEBs, hemodynamic effects: (2)
1) Negative inotropes (all) 2) Nifedipine increases CO,
HR, contractility 3) Diltiazem has least
negative inotropy 4) Verapamil can
significantly decrease myocardial function
5) Diltiazem is the most potent coronary vasodilator
![Page 15: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/15.jpg)
15
Nifedipine:
1) Is contraindicated in hypertensive emergencies
2) Is useful for treatment of hypertension in the PACU
3) Indications
![Page 16: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/16.jpg)
16
Esmolol:
1) Half-life 9 min 2) Prolonged duration with
atypical plasma
cholinesterase 3) Beta-1 selective 4) Causes more hypotension
than propranolol 5) Safe in bronchospastic
disease 6) Prolongs duration of
succinylcholine 7) Useful to convert acute
Atrial Flutter to sinus
![Page 17: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/17.jpg)
17
Which Beta Blocker has longest duration of action?
Labetalol Propranolol Nadolol Metoprolol Atenolol Acebutolol Bisoprolol
![Page 18: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/18.jpg)
18
Enalaprilat:
1) Is a pro-drug of enalapril, given intravenously
2) Is contraindicated in renovascular
hypertension 3) IV dose is 0.625 - 1.25 mg
q6h 4) Postinduction hypotension
is more common if ACEIs taken on the morning of surgery
5) Hypotension can be treated with crystalloid, phenylephrine, and vasopressin
![Page 19: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/19.jpg)
19
Angiotensin Receptor Blockers:
1) Act independently of ACE
2) Antagonize Angiotensin I at AT1 receptors
3) Losartan is the prototype
4) Side effects profile is similar to ACEI’s
![Page 20: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/20.jpg)
20
Ephedrine:
1) Is a sympathomimetic, a synthetic, and a catecholamine
2) Has both direct and indirect actions at adrenergic nerve endings
3) May produce arrhythmias 4) Hemodynamic profile is
the same as Epinephrine 5) Is limited by
tachyphylaxis 6) Comes from a Chinese
plant "Ma Huang" 7) Can be given IV, IM, PO
![Page 21: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/21.jpg)
21
Ephedrine: (2)
1) Is a sympathomimetic, a synthetic, and a catecholamine
2) Has both direct and indirect actions at adrenergic
nerve endings 3) May produce arrhythmias 4) Hemodynamic profile is the
same as Epinephrine 5) Is limited by tachyphylaxis 6) Comes from a Chinese
plant "Ma Huang" 7) Can be given IV, IM, PO 8) Associated with lower
umbilical Artery pH than Phenylephrine
![Page 22: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/22.jpg)
22
Phenoxybenzamine:
1) Is a nonselective alpha antagonist
2) Requires up to 2 weeks to control BP in pheochromocytoma
3) Causes orthostatic hypotension, miosis, nasal stuffiness, tachycardia, impotence
4) Uses include:– Preop control with pheo– Excessive vasoconstriction e.g.
Raynaud’s– Acute hypertensive emergencies
5) Should be given prior to beta blockade
![Page 23: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/23.jpg)
23
Amiodarone:
1) What are indications? 2) What is unique about PK 3) What is IV dosing:
![Page 24: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/24.jpg)
24
Side effects of amiodarone:
1) Thyroid hyperfunction 2) Thyroid hypofunction 3) Bradycardia 4) Pulmonary fibrosis 5) Facial discolouration
![Page 25: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/25.jpg)
25
NaHCO3 in cardiac arrest:
1) Indicated with pre-existing metabolic acidosis, hyperkalemia, TCA overdose
2) Prolongs survival in animal models
3) May precipitate with catecholamines
4) Improves ability to defibrillate
![Page 26: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/26.jpg)
26
Useful drugs in aortic dissection:
1) Beta blockers 2) Nitroprusside 3) Both of above 4) Hydralazine 5) CEBs
![Page 27: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/27.jpg)
27
Calcium:
1) Theoretical detrimental effects in cardiac arrest
2) Can precipitate dig toxicity
3) Serum ionised Ca++ does not decrease when citrated blood given < 100mL / 70kg / min
4) CaCl2 contains 3x as much Ca++ as gluconate but is irritating to veins
5) List 4 indications
![Page 28: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/28.jpg)
28
Withdrawal syndromes may occur with (1):
1) Diltiazem 2) Beta blockers 3) Clonidine 4) Methyldopa 5) Reserpine 6) ACEIs 7) CEBs
![Page 29: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/29.jpg)
29
Withdrawal syndromes may occur with: (2)
1) Diltiazem 2) Beta blockers 3) Clonidine 4) Methyldopa 5) Reserpine 6) ACEIs 7) CEBs
![Page 30: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/30.jpg)
30
Verapamil
1) More effective than digoxin in controlling HR in AF
2) Ineffective in converting AF to NSR
3) CXD in VT 4) CXD in SVT with
Aberrancy due to WPW 5) CXD in narrow complex
SVT 6) CXD in AF with WPW
![Page 31: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/31.jpg)
31
A 50 kg patient is having a CAPD catheter removed
The patient is on Nifedipine for HTN
She is being treated with Vancomycin for CAPD catheter-related peritonitis
Why is “40 of Roc” asking for trouble?
![Page 32: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/32.jpg)
32
Amrinone:
1) A nonspecific phosphodiesterase inhibitor
2) Increases cAMP which increases intracellular Ca++
3) Increases HR
4) Increases MVO2
5) Has T/2 3.5 hr 6) Effective in presence of
Beta- blockade
![Page 33: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/33.jpg)
33
Milrinone
1) A second generation PDE-5 inhibitor
2) More potent than Amrinone
3) Side effects include thrombocytopenia
4) Improves diastolic relaxation
5) Decreases pulmonary vascular resistance
6) Causes hypotension
7) Rapid onset inotropic effect
![Page 34: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/34.jpg)
34
Phenylephrine:
1) Has effects similar to Norepinephrine
2) Decreases coronary perfusion
3) Causes miosis
4) Can decrease CO
5) Overdose should be treated withBeta-blockers
![Page 35: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/35.jpg)
Extravasation of vasopressors
1) List some drugs causing skin necrosis
2) Tx
3) Other effects of extravasation
![Page 36: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/36.jpg)
36
Effects of Dopamine
1) Diminished response in CHF
2) Skin necrosis with extravasation
3) Renal vasoconstriction
4) Increased MVO2
5) Shifts blood flow away from skeletal muscle
6) Causes hypoglycemia 7) May impair functional
myocardial recovery following ischemic
injury
![Page 37: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/37.jpg)
37
Effects of Dopamine (2)
1) Diminished response in CHF
2) Skin necrosis with extravasation
3) Renal vasoconstriction 4) Increased MVO2 5) Shifts blood flow away
from skeletal muscle 6) Causes hypoglycemia 7) May impair functional
myocardial recovery following ischemic injury
![Page 38: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/38.jpg)
38
Renal Dose Dopamine
1) Decreases incidence of ARF in surgical patients at risk
2) Improve creatinine clearance after a renal insult
3) Is antagonized by Droperidol and Metoclopramide
4) Improves Na+ and H2O excretion
5) Can cause intrapulmonary shunting and mesenteric ischemia
6) “bad medicine”
![Page 39: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/39.jpg)
39
Dobutamine receptor effects:
1) Is a pure Beta-1 agonist 2) Produces vasoconstrictive
effects through stimulation of alpha receptors
3) Produces vasodilatory effects through stimulation of Beta-2 receptors
4) Produces inotropic effects through
myocardial alpha-1 receptors
5) May produce vasoconstriction in beta-blocked patients
![Page 40: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/40.jpg)
40
Dobutamine receptor effects (2):
1) Is a pure Beta-1 agonist 2) Produces vasoconstrictive
effects through stimulation of alpha receptors
3) Produces vasodilatory effects through stimulation of Beta-2 receptors
4) Produces inotropic effects through
myocardial alpha-1 receptors
5) May produce vasoconstriction in beta-blocked patients
![Page 41: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/41.jpg)
41
Dobutamine, hemodynamic effects:
1) Increased SV 2) Decreased SVR, PVR 3) No effect on RBF 4) Improves coronary
supply:demand ratio 5) BP increases, decreases,
or remains same 6) Has minimal effect on HR
![Page 42: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/42.jpg)
42
Isoproterenol, indications:
1) 3rd Degree heart block 2) Post cardiac transplant 3) Countereffect profound
Beta blockade 4) Post CABG surgery low
output syndrome 6) Asthma 7) Torsade de Pointes
![Page 43: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/43.jpg)
43
NTG, most important mechanism in myocardial
ischemia 1) Coronary vasodilation 2) Decreased LVEDP 3) Decreased afterload 4) Redistribution of flow to
ischemic areas 5) Vasodilation of pulmonary
arteries and veins
![Page 44: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/44.jpg)
44
NTG, list clinical indications
1) Approved
2) Off Label
3) Other
![Page 45: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/45.jpg)
45
Glucagon:
1) Acts independently of Beta receptors and
Phosphodiesterase 2) Increases myocardial
contractility and HR 3) Stimulates release of
catecholamines 4) Metabolic effects include
hypokalemia, hypoglycemia
5) Used to diagnose pheochromocytoma
6) Inhibits gastric motility
![Page 46: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/46.jpg)
46
What are mechanisms for the decrease in HR with digoxin
therapy in CHF? 1) Prolongation of AV node
conduction 2) Enhanced
parasympathetic nervous system activity
3) Dose-related increase in myocardial
contractility 4) Reduced sympathetic
tone
![Page 47: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/47.jpg)
47
Digoxin, List Some Precautions/Contraindication
s: 1) Hypokalemia,
hypomagnesemia, hypercalcemia
2) Hypertrophic cardiomyopathies
3) WPW 4) Pt requiring cardioversion 5) Impaired renal function 6) SA node dysfunction
![Page 48: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/48.jpg)
48
List common cardiac manifestations of digoxin
toxicity Answers:
Atrial tachycardia with block– Commonest
Junctional tachycardias, escape rhythms
Bigeminy, PVCs, VT VF
– Commonest cause of death
Worsening CHF
![Page 49: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/49.jpg)
49
Diastolic perfusion time is increased by:
1) Dobutamine 2) Isoproterenol 3) Propranolol
![Page 50: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/50.jpg)
50
Epinephrine
1) Decreases RBF 2) Alpha effect in skeletal
muscle 3) Beta effect in skin,
mucosa 4) Drug of choice for ____
shock 5) May decrease cardiac
output 6) Overdose best treated
with Propranolol
![Page 51: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/51.jpg)
51
The initial hemodynamic effects of Dopamine, Phenylephrine,
and Epinephrine include:
1) Increased afterload 2) Increased contractility 3) Increased HR 4) Increased preload
![Page 52: Cardiovascular Drugs Chris G. Wherrett, MD, FRCPC Department of Anesthesiology Ottawa Hospital General Campus October 11, 2012](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649ee85503460f94bf91d0/html5/thumbnails/52.jpg)
52
Adenosine
1) Indicated in atrial flutter 2) A1 receptors mediate SA
node slowing and AV Node conduction
delay 3) Side effects include
flushing, headache, bronchospasm, chest pain, hypotension, and
tachycardia 4) Should be given by slow
IV push